NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation. - Wikidata - wikimedia - TriplyDB

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

http://www.wikidata.org/entity/Q34565548

about

Activated human T cells express alternative mRNA transcripts encoding a secreted form of RANKL MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity Negative autoregulation of RANKL and c-Src signaling in osteoclasts Forkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expression Placotylene A, an inhibitor of the receptor activator of nuclear factor-κB ligand-induced osteoclast differentiation, from a Korean sponge Placospongia sp.Embryonic Development of the Bicuspid Aortic Valve.Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis Baicalin positively regulates osteoclast function by activating MAPK/Mitf signalling.Cloning and characterization of osteoclast precursors from the RAW264.7 cell line Transcriptional regulation of bone and joint remodeling by NFAT NIP45 negatively regulates RANK ligand induced osteoclast differentiation.TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages.Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.Proapoptotic function of integrin beta(3) in human hepatocellular carcinoma cells.The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints.Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice.NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP).NADPH oxidase gp91(phox) contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1 Transgenic mice with OIP-1/hSca overexpression targeted to the osteoclast lineage develop an osteopetrosis bone phenotype.RCANs regulate the convergent roles of NFATc1 in bone homeostasis.Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications.Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts.Targeting integrins to promote bone formation and repair.Regulatory mechanisms of RANKL presentation to osteoclast precursors.Repositioning Potential of PAK4 to Osteoclastic Bone Resorption.The effects of tumour necrosis factor-α on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes.Dexamethasone increases αvβ3 integrin expression and affinity through a calcineurin/NFAT pathway.Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis.Nordihydroguaiaretic acid inhibition of NFATc1 suppresses osteoclastogenesis and arthritis bone destruction in rats.Decreased SH3BP2 inhibits osteoclast differentiation and function Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.Impaired micro-RNA pathways diminish osteoclast differentiation and function.The Beneficial Effect of Praeruptorin C on Osteoporotic Bone in Ovariectomized Mice via Suppression of Osteoclast Formation and Bone Resorption.Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein.Decoy receptor 3 suppresses RANKL-induced osteoclastogenesis via down-regulating NFATc1 and enhancing cell apoptosis.Clinically Relevant Concentrations of Ketamine Inhibit Osteoclast Formation In Vitro in Mouse Bone Marrow Cultures.Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems.

P2860

Q24632345-E15ED4F6-53D4-49A6-AFB9-7DC3E21A8608 Q26752588-E0707784-CC2A-4F44-9401-62DA2ECA67C5 Q27008993-AF319D60-9A03-47A5-A7EE-9B9700F3E4A2 Q28274725-F45013E0-FA36-4361-9642-E65EDFB17CB4 Q28307600-04C4F499-DE46-408B-B811-14761420BC13 Q28587296-5AB13561-CFE3-4316-A368-453214754B67 Q33575706-0F6E1089-CE9A-49BC-9169-57ACD7DAD66D Q33708015-9E654EC5-5732-4A8F-9C8F-13BFA3913C73 Q33736852-78A287CA-8FF9-48D1-915E-FA53409A390D Q33844646-EE401295-3D7C-4CEE-9315-0A74EBDB2091 Q33906787-733D9DEB-9EC0-4F5E-9B1B-A5D79422B8D9 Q33998768-E8913BD1-F8FB-488B-9101-835116394279 Q34128188-FB806F7C-841D-450F-8DA2-90CB4F117FFD Q34533668-58BECA38-83A0-4033-B20F-99FF3B0AD5DE Q34968667-56736E17-B465-4B10-9EE0-7831AB6F0A03 Q36487636-D4C07562-7A66-4478-9809-3ACDC3064B73 Q36857816-E655A052-0A2E-45B9-B745-05A216B7DD5C Q36907683-03DD161C-9DD0-4C59-8970-474B9D0D318F Q37143375-8FA798FE-E8CE-4FBA-A72C-AF4EA9CB1FA4 Q37302319-C16E2931-71C9-47B9-8532-97898F6BAEFF Q37448881-F5121828-7D27-4C7E-B65F-71EE5DA4F464 Q37453357-B64645FD-396B-44CC-BB87-4EF17EE5F9FB Q37472044-6E6363E1-FB3C-42F7-A572-12C3BF09F33E Q37829690-B5B564E8-D291-4F23-9718-165F363EB68C Q38074961-9D7C9561-D6FA-4D0B-ACC9-8F2A2C244329 Q38077443-14E5FE31-97D9-477E-9D25-55415D0ECBA5 Q38183261-2D35ECEE-3D06-4FA0-AD8E-341248463F06 Q38428915-1EC6459D-5451-452B-9410-170C38152CEA Q38669228-52DB7F74-26FC-4A2B-8CFF-176F19D754DC Q39085200-27EE2C24-A23D-4A48-983E-A6C22D2903DE Q39139785-4EBA518D-2E5A-4793-BCB2-2FBA847B450C Q39264023-8502B0FF-B66D-447B-A0CB-2B6FD8F1200C Q39568444-D26E3840-CC3E-4200-B603-F5716535A2A8 Q39868307-C759F368-CB3A-45EF-827C-A1E4AA55157D Q39908266-009A9EA1-542D-47AE-A9EE-BD4381F20C70 Q41684447-03415BD1-503D-4B1C-82FF-F4D4502F61F2 Q42270419-981E457D-4AA6-47E3-9419-EFEFA4F55ADF Q44496075-6B96077B-01F2-4D95-94D1-2CB6F23589F0 Q47373904-D8470F01-D872-4097-B8DB-0BEBEDA5E508 Q47944184-9B70613D-32B5-4184-ABF5-F99770788DA0

P2860

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

http://www.wikidata.org/entity/Q34565548

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

@ast

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

@en

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

@nl

type

label

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

@ast

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

@en

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

@nl

prefLabel

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

@ast

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

@en

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

@nl

P1433

Q34565548-96D6E9D2-2493-4477-A310-D57A14AC25FC

P1476

Q34565548-997ABB63-BD16-4D0F-84D1-70B74BE28E4B

P2093

Q34565548-14558CA5-1892-4910-A1A2-21AB58F5100F

Q34565548-4083D007-0F59-4E9A-8657-18E673727272

Q34565548-8A98BE6D-D1F3-41A1-84EB-093B57DD00D3

Q34565548-C189D862-C9CC-4394-A4DA-FB0AD266F847

Q34565548-C57D3A19-479F-4EA2-A92C-87FF24C790EE

Q34565548-CE755CFD-8E29-40A2-AB23-46908B86B37E

P2860

Q34565548-0F18E503-B2D2-4F47-8C1B-9CD2DFDAD3CC

Q34565548-10AD7689-2B01-421C-9A21-137F6AEFD578

Q34565548-156641F5-B567-4FC9-BA79-AACBCF05F187

Q34565548-2BFC0460-7168-43CD-AF76-AFBAEE35B9A6

Q34565548-2C59FEDB-5A99-42E2-8FAA-9A4562390866

Q34565548-32671DEC-1963-41AC-A5B1-28FEC97CB3AE

Q34565548-3F23F31F-E3FF-45F6-B77B-0262ACEFFD6C

Q34565548-4DF6CEC6-E531-49D9-9EC1-B6EF5A2B0BC0

Q34565548-6C435BC1-3C22-46D0-BCF3-7D175FF1D6EE

Q34565548-6F268109-F15D-48BA-9738-B9F77E8A9F29

P304

Q34565548-38904C38-35D9-4D20-97AC-3F92B150440A

P31

Q34565548-E2B097DC-AE56-4EFC-8AA5-40C9287C5934

P356

Q34565548-A71381AA-BC9B-4090-AB19-0FC5B1E3F75C

P407

Q34565548-F6E2E669-3771-4C91-ABCE-6D91B23595FD

P478

Q34565548-81D14524-35C8-4924-9372-A46D9B47BED5

P577

Q34565548-A69AE981-B931-495B-848B-4B5A742B30A1

P5875

Q34565548-E54008DE-2196-431C-9F19-E203040C3756

P698

Q34565548-87F58C2F-33A4-4D90-8873-8D909026D4FB

P932

Q34565548-37AB7327-9DCE-4068-B960-6AB3B7F8352A

P356

J.GENE.2005.12.012

P1433

P1476

NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.

@en

P2093

Joseph D Fleming

http://www.w3.org/2001/XMLSchema#string

Kevin P McHugh

http://www.w3.org/2001/XMLSchema#string

Merrilee Flannery

http://www.w3.org/2001/XMLSchema#string

Nicole C Walsh

http://www.w3.org/2001/XMLSchema#string

Steven R Goldring

http://www.w3.org/2001/XMLSchema#string

Tania N Crotti

http://www.w3.org/2001/XMLSchema#string

P2860

Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1

NF-AT components define a family of transcription factors targeted in T-cell activation

Transcription factors of the NFAT family: regulation and function

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

Cloning and characterization of the murine beta(3) integrin gene promoter: identification of an interleukin-4 responsive element and regulation by STAT-6.

Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.

Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts

Partners in transcription: NFAT and AP-1.

TAT-mediated protein transduction into mammalian cells.

P304

92-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.GENE.2005.12.012

http://www.w3.org/2001/XMLSchema#string

P407

P478

372

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7265194

http://www.w3.org/2001/XMLSchema#string

P698

16513293

http://www.w3.org/2001/XMLSchema#string

P932

1447605

http://www.w3.org/2001/XMLSchema#string